company, and the global leader in total artificial heart technology, is pleased to announce that the China National Intellectual Property Administration ("CNIPA") has notified the Company of the ...
TUCSON, Ariz., Jan. 9, 2025 /PRNewswire/ -- SynCardia Systems, LLC (“SynCardia”, or the “Company”), a Picard Medical, Inc. company, and the global leader in total artificial heart technology, is ...
An initial group of over 50 patients is set to receive temporary valves made of fibres which will act as 'scaffoling' that canimplanted, integrate with the body's cells.
The valve replacement has often meant another open-heart surgery. “Receiving CE Mark for the Harmony TPV system helps advance options for minimally invasive solutions for physicians to treat ...